The ATM/ATR DNA damage checkpoint functions in the maintenance of genetic stability and some missense variants of the ATM gene have been shown to confer a moderate increased risk of prostate cancer. However, whether inactivation of this checkpoint contributes directly to prostate specific cancer predisposition is still unknown. Here, we show that exposure of non-malignant prostate epithelial cells (HPr-1AR) to androgen led to activation of the ATM/ATR DNA damage response and induction of cellular senescence. Notably, knockdown of the ATM gene expression in HPr-1AR cells can promote androgen-induced TMPRSS2: ERG rearrangement, a prostate-specific chromosome translocation frequently found in prostate cancer cells. Intriguingly, unlike the non...
Abstract Background The cellular effects of androgen are transduced through the androgen receptor, w...
DNA damage is a key factor both in the evolution and treatment of cancer. Genomic instability is a c...
Background: Androgen deprivation therapy remains the first-line therapy option for prostate cancer, ...
The ATM/ATR DNA damage checkpoint functions in the maintenance of genetic stability and some missens...
<div><p>The ATM/ATR DNA damage checkpoint functions in the maintenance of genetic stability and some...
The ATM/ATR DNA damage checkpoint functions in the maintenance of genetic stability and some missens...
The ATM/ATR DNA damage checkpoint functions in the maintenance of genetic stability and some missens...
AbstractThe ATM (ataxia telangiectasia mutated) kinase plays an essential role in maintaining genome...
<p>(A) Knockdown of the ATM and ATR expression in HPr-1 AR cells. Cells were transiently transfected...
Androgen receptor (AR) plays a role in maintaining telomere stability in prostate cancer cells, as A...
DNA damage response (DDR) includes the activation of numerous cellular activities that prevent dupli...
ABSTRACT We demonstrate that the androgen receptor (AR) regulates a transcriptional pro-gram of DNA ...
In prostate cancer, androgen deprivation therapy (ADT) enhances the cytotoxic effects of radiotherap...
Telomere stability is important for cell viability, as cells with telomere DNA damage that is not re...
Androgens stimulate the proliferation of epithelial cells in the prostate by activating topoisomeras...
Abstract Background The cellular effects of androgen are transduced through the androgen receptor, w...
DNA damage is a key factor both in the evolution and treatment of cancer. Genomic instability is a c...
Background: Androgen deprivation therapy remains the first-line therapy option for prostate cancer, ...
The ATM/ATR DNA damage checkpoint functions in the maintenance of genetic stability and some missens...
<div><p>The ATM/ATR DNA damage checkpoint functions in the maintenance of genetic stability and some...
The ATM/ATR DNA damage checkpoint functions in the maintenance of genetic stability and some missens...
The ATM/ATR DNA damage checkpoint functions in the maintenance of genetic stability and some missens...
AbstractThe ATM (ataxia telangiectasia mutated) kinase plays an essential role in maintaining genome...
<p>(A) Knockdown of the ATM and ATR expression in HPr-1 AR cells. Cells were transiently transfected...
Androgen receptor (AR) plays a role in maintaining telomere stability in prostate cancer cells, as A...
DNA damage response (DDR) includes the activation of numerous cellular activities that prevent dupli...
ABSTRACT We demonstrate that the androgen receptor (AR) regulates a transcriptional pro-gram of DNA ...
In prostate cancer, androgen deprivation therapy (ADT) enhances the cytotoxic effects of radiotherap...
Telomere stability is important for cell viability, as cells with telomere DNA damage that is not re...
Androgens stimulate the proliferation of epithelial cells in the prostate by activating topoisomeras...
Abstract Background The cellular effects of androgen are transduced through the androgen receptor, w...
DNA damage is a key factor both in the evolution and treatment of cancer. Genomic instability is a c...
Background: Androgen deprivation therapy remains the first-line therapy option for prostate cancer, ...